Sample Set Annotation Tool: Gene expression data from CD14++ CD16- classical monocytes from healthy volunteers and patients with pancreatic ductal adenocarcinoma-GSE60601

Study Design
Assay
Sample Info
Files
Info
Samples
Group Sets
Analysis

Purpose

Hypothesis

Experimental Design

Differentially expressed genes were identified comparing gene expression profiles between healthy and PDAC.

Experimental Variables

Controls

Methods

Additional Information

Expected Samples:

12 Samples Loaded: 12

Species

Human (Homo sapiens)

Sample Source

Monocytes

Disease

Pancreatic ductal adenocarcinoma

Treatment Protocol

Growth Protocol

Extraction Protocol

Storage Conditions

Sample Set Spreadsheet

Please log in in order to upload files.

Samples Preview

Sample ID	Age	!Sample_title	treatment	tissue	disease state
GSM1483156	63	HEALTHY1	none	monocytes	Healthy
GSM1483157	60	HEALTHY2	none	monocytes	Healthy
GSM1483158	58	HEALTHY3	none	monocytes	Healthy
GSM1483159	63	PDAC1	none	monocytes	Locally advanced, unresectable Pancreatic Ductal Adenocarcinoma (PDAC) prior to any chemotherapy treatment
GSM1483160	80	PDAC2	none	monocytes	Locally advanced, unresectable Pancreatic Ductal Adenocarcinoma (PDAC) prior to any chemotherapy treatment

Please log in in order to upload files.

File
sampleset4000054_sampleannotations.csv Sample Set Spreadsheet

Samples Viewer / Editor

All fields are editable except the "Sample ID" column. To edit a cell, click within the cell. To edit a "date" cell, click on the calendar icon. To cancel an edit, press the ESC key.

Sample ID	Age	!Sample Title	Treatment	Tissue	Disease state	Sex	Disease Status
GSM1483156	63	HEALTHY1	none	monocytes	Healthy	f	HEALTHY
GSM1483157	60	HEALTHY2	none	monocytes	Healthy	m	HEALTHY
GSM1483158	58	HEALTHY3	none	monocytes	Healthy	m	HEALTHY
GSM1483159	63	PDAC1	none	monocytes	Locally advanced, unresectable Pancreatic Ductal Adenocarcinoma (PDAC) prior to any chemotherapy treatment	f	PDAC
GSM1483160	80	PDAC2	none	monocytes	Locally advanced, unresectable Pancreatic Ductal Adenocarcinoma (PDAC) prior to any chemotherapy treatment	f	PDAC
GSM1483161	68	PDAC3	none	monocytes	Locally advanced, unresectable Pancreatic Ductal Adenocarcinoma (PDAC) prior to any chemotherapy treatment	m	PDAC
GSM1483163	75	PDAC4	none	monocytes	Locally advanced, unresectable Pancreatic Ductal Adenocarcinoma (PDAC) prior to any chemotherapy treatment	m	PDAC
GSM1483165	60	PDAC5	none	monocytes	Locally advanced, unresectable Pancreatic Ductal Adenocarcinoma (PDAC) sample taken 30 minutes after FOLFIRNOX treatment ended	m	PDAC
GSM1483167	69	PDACPRE1	none	monocytes	Locally advanced, unresectable Pancreatic Ductal Adenocarcinoma (PDAC) prior to any chemotherapy treatment	f	PDACPRE
GSM1483169	71	PDACPRE2	none	monocytes	Locally advanced, unresectable Pancreatic Ductal Adenocarcinoma (PDAC) prior to any chemotherapy treatment	m	PDACPRE
GSM1483171	69	PDACPOST1	Folfirinox	monocytes	Locally advanced, unresectable Pancreatic Ductal Adenocarcinoma (PDAC) prior to any chemotherapy treatment	f	PDACPPOST
GSM1483173	71	PDACPOST2	Folfirinox	monocytes	Locally advanced, unresectable Pancreatic Ductal Adenocarcinoma (PDAC) prior to any chemotherapy treatment	m	PDACPOST

Group Sets View in Gene Expression Browser

Name
All Samples		View
Disease status	Default	View
In order to make new Group Sets or change settings, please log in.

Module Analysis

Group Set
All Samples
Disease status

SIDRA